Anti-CDKN2C/p18 INK4c Antibody (4N303) is a Rabbit antibody targeting CDKN2C/p18 INK4c. Anti-CDKN2C/p18 INK4c Antibody (4N303) can be used in IF, IHC-Fr, IHC-P, IP, WB.

IgG

4N303

Human (predicted:Mouse,Rat)

1. Western blot analysis of Ramos cell lysate. Using CDKN2C/p18 INK4c (TMAB-04186) monoclonal antibody at 1: 1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r. T. for 60 min.
2. Paraformaldehyde-fixed, paraffin embedded Human Glioma; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with CDKN2C/p18 INK4c Monoclonal Antibody, Unconjugated (TMAB-04186) at 1:200 overnight at 4°C, followed by conjugation to the Goat Anti-Rabbit IgG H&L-HRP and DAB staining.
3. Paraformaldehyde-fixed, paraffin embedded Human Cerebrum; Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15 min; The section was incubated with CDKN2C/p18 INK4c Monoclonal Antibody, Unconjugated (TMAB-04186) at 1:200 overnight at 4°C, followed by conjugation to the Goat Anti-Rabbit IgG H&L-HRP and DAB staining.

IF=1:100-500; IHC-Fr=1:100-500; IHC-P=1:100-500; IP=1:20-50; WB=1:1000-2000

Monoclonal

A synthesized peptide: human CDKN2C

Human

CDKN2C

Cyclin-dependent kinase 4 inhibitor C

Interacts strongly with CDK6, weakly with CDK4. Inhibits cell growth and proliferation with a correlated dependence on endogenous retinoblastoma protein RB.